会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Test strip for the assay of an analyte in a liquid sample
    • 用于液体样品中分析物测定的试纸
    • US06316264B1
    • 2001-11-13
    • US09466637
    • 1999-12-17
    • Paul F. CoreyMichael J. PugiaGary E. Rehm
    • Paul F. CoreyMichael J. PugiaGary E. Rehm
    • G01N3122
    • G01N33/521Y10T436/173076
    • An improved test strip for determining the presence or concentration of unknown or a constituent in a liquid test sample is disclosed. The test strip comprises a support strip and a test pad, wherein the test pad includes a carrier matrix incorporating a reagent composition capable of interacting with the constituent of interest to produce a detectable or measurable response. The test strip further comprises an infrared dye, applied either to the support strip or incorporated into a test pad, which ensures proper alignment of the test strip in an apparatus having a detection system for the detectable or measurable response. The improved test strip reduces the number of erroneous assays for the constituent of interest.
    • 公开了一种改进的测试条,用于确定液体测试样品中未知物或成分的存在或浓度。 测试条包括支撑带和测试垫,其中测试垫包括载体矩阵,其包含能够与感兴趣的成分相互作用以产生可检测或可测量的响应的试剂组合物。 测试条进一步包括红外染料,施加到支撑条上或并入测试垫中,这确保测试条在具有用于可检测或可测量响应的检测系统的装置中的适当对准。 改进的测试条减少了感兴趣的成分的错误测定的数量。
    • 10. 发明申请
    • ADIPONECTIN RECEPTOR FRAGMENTS AND METHODS OF USE
    • ADIPONECTIN受体片段和使用方法
    • US20090143275A1
    • 2009-06-04
    • US12169983
    • 2008-07-09
    • Michael J. PugiaRui Ma
    • Michael J. PugiaRui Ma
    • A61K38/02A61P3/10A61P35/00
    • C07K14/72A61K38/00
    • Methods are disclosed of treating diabetes, abnormal adipocyte activity, and insulin resistance using C-terminal fragments of adiponectin receptor R1. Methods of causing the secretion of insulin in healthy and diabetic patients using C-terminal fragments of adiponectin receptor R1 are also disclosed. In addition, methods are disclosed of increasing the insulin levels in healthy patients using C-terminal fragments of adiponectin receptor R1. In addition, methods of treating abnormal adipocyte activity, treating metabolic syndrome, causing insulin secretion, increasing insulin levels, inhibiting insulin degradation enzyme, treating Alzheimer's disease, treating cardiovascular disease associated with adiponectin levels, inhibiting ADAM-17 enzyme, treating a condition associated with TNF-alpha, and treating a condition associated with HER2-neu are disclosed. Compositions, dosage forms, and kits are also disclosed.
    • 公开了使用脂联素受体R1的C末端片段治疗糖尿病,异常脂肪细胞活性和胰岛素抵抗的方法。 还公开了使用脂联素受体R1的C末端片段在健康和糖尿病患者中分泌胰岛素的方法。 此外,公开了使用脂联素受体R1的C末端片段增加健康患者的胰岛素水平的方法。 另外,处理异常脂肪细胞活性,治疗代谢综合征,引起胰岛素分泌,增加胰岛素水平,抑制胰岛素降解酶,治疗阿尔茨海默氏病,治疗与脂联素水平相关的心血管疾病,抑制ADAM-17酶,治疗与 公开了TNF-α和治疗与HER2-neu相关的病症。 还公开了组合物,剂型和试剂盒。